The Library

Legal aspects of contraceptive implants

Tools

Rowlands, Sam (2010) Legal aspects of contraceptive implants. Journal of Family Planning and Reproductive Health Care, Vol.36 (No.4). pp. 243-248. ISSN 1471-1893

Preview

PDF
WRAP_Rowlands_SubdermalimplantslegalJFPRHCOct2010_Uni_repos_version.pdf - Accepted Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (478Kb)

Official URL: http://dx.doi.org/10.1783/147118910793048485

Abstract

Key message points - There has been litigation in relation to the three types of harm associated with contraceptive implants: non-insertion, deep insertion and nerve injury. - Recommendations for safe clinical practice can be derived from analysis of legal cases and published case reports. - Nerve injury has invariably been caused by clinicians without upper limb surgical skills attempting difficult removals. - The launch of the updated single-rod implant (Nexplanon®) may hold the best possibility for harm reduction. - Litigation in relation to side effects can lead to the withdrawal of safe and effective contraceptive products, so reducing choice for women

Item Type:	Journal Item
Subjects:	K Law > KD England and Wales R Medicine > RG Gynecology and obstetrics
Divisions:	Faculty of Medicine > Warwick Medical School > Institute of Clinical Education (ICE) Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Contraceptive drug implants -- Law and legislation -- Great Britain, Medical errors -- Great Britain
Journal or Publication Title:	Journal of Family Planning and Reproductive Health Care
Publisher:	Professional, Managerial & Healthcare Publications Ltd.
ISSN:	1471-1893
Date:	October 2010
Volume:	Vol.36
Number:	No.4
Number of Pages:	6
Page Range:	pp. 243-248
Identification Number:	10.1783/147118910793048485
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
References:	(1) Vincent C. Patient safety. Edinburgh: Churchill Livingstone; 2006. (2) Merry AF. How does the law recognize and deal with medical errors? JRSM 2009; 102:265-271. (3) Bismark M, Paterson R. No-fault compensation in New Zealand: harmonizing injury compensation, provider accountability, and patient safety. Health Affairs 2006; 25:278-283. (4) Waters A. GPs advised to stop inserting Norplant. GP 1995; 29 September 1995. (5) Rowlands S. Protecting new contraceptive methods. Contraceptive Education Bulletin 1997; Winter 1997:5. (6) Robins J. Norplant case collapses as tobacco multi-party action trips up in court. Law Society Gazette 1999; 10 February 1999. (7) Boonstra H, Duran V, Gamble VN, Blumenthal P, Dominguez L, Pies C. The 'boom and bust' phenomenon: the hopes, dreams, and broken promises of the contraceptive revolution. Contraception 2000; 61:9-25. (8) Entwistle VA, Watt IS, Johnson F. The case of Norplant as an example of media coverage over the life of a new health technology. Lancet 2000; 355:1633-1636. (9) Committee on Contraceptive Research and Development. Contraceptive research, introduction, and use: lessons from Norplant. Washington DC: Institute of Medicine; 1998. (10) The single-rod contraceptive implant. Washington DC: Association of Reproductive Health Professionals; 2008. (11) Mansour D. Nexplanon® - what Implanon did next. J Fam Plann Reprod Health Care 2010. (12) Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt H-J et al. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010; 82:243-249. (13) Mascarenhas L. Insertion and removal of Implanon®. Contraception 1998; 58 (Suppl 6):79S-83S. (14) Croxatto HB, Mäkäräinen L. The pharmacodynamics and efficacy of Implanon. Contraception 1998; 58:91S-97S. (15) Rowlands S, Sujan M-A, Cooke M. Risk management aspects of contraceptive implants. J Fam Plann Reprod Health Care. In press 2010. (16) Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salina F, Llabres S, Autret-Leca E. Insertion problems, removal problems and contraception failures with Implanon® [in French]. Gynécologie Obstétrique & Fertilité 2005; 33:986-990. (17) Stillwell S, Sheppard P, Searle S. The impalpable Implanon®: a case report. J Fam Plann Reprod Health Care 2003; 29:156-157. (18) Singh M, Mansour D, Richardson D. Location and removal of non-palpable Implanon® implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care 2006; 32:153-156. (19) http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Medicines/Reportingsuspectedadversedrugreactions/index.htm (Accessed 27 January 2010). 2010. (20) Court imposes the burden of proof on the women in case of Implanon unintended pregnancies [in Dutch] http://juridischdagblad.nl/content/view/5549/53/ (Accessed 17 July 2009). The Legal Daily 2007 Aug 28. (21) McFarlane v Tayside Health Board [2000] 2 AC 59, MLC 0127, HL. 2000. Ref Type: Statute (22) Wood M, Price S. Lawsuits flying over 'failed' contraceptive. Sydney Morning Herald 2005 Feb 13. (23) Dunson TR, Amatya RN, Kreuger SL. Complications and risk factors associated with the removal of Norplant implants. Obstet Gynecol 1995; 85:543-547. (24) Walling M. How to remove impalpable Implanon® implants. J Fam Plann Reprod Health Care 2005; 31:320-321. (25) Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 2008; 34:9-12. (26) Navani M, Robinson C. Clinical challenge with Implanon® removal: a case report. J Fam Plann Reprod Health Care 2005; 31:161-162. (27) Ismail H, Mansour D, Singh M. Migration of Implanon®. J Fam Plann Reprod Health Care 2006; 32:157-159. (28) Cozens NJA. Contraceptive implants: high resolution ultrasonography facilitates removal. BMJ 1996; 313:880. (29) Evans R, Holman R, Lindsay E. Migration of Implanon®: two case reports. J Fam Plann Reprod Health Care 2005; 31:71-72. (30) Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception 2006; 73:325-330. (31) Sarma SP, Silverstein M, Lewis C. Removal of a Norplant® implant located near a major nerve using interventional radiology-digital subtraction fluoroscopy. Contraception 1998; 58:387-389. (32) Westerway SC, Picker R, Christie J. Implanon implant detection with ultrasound and magnetic resonance imaging. Aust NZ J Obstet Gynaecol 2003; 43:346-350. (33) Newton MP, Mascarenhas L, Xiao-Feng L, Newton J. Experience with contraceptive implants: removal technique, classification of difficulties and the importance of correct placement. Br J Fam Planning 1995; 21 (Suppl):14-16. (34) Nelson AL, Sinow RM. Real-time ultrasonographically guided removal of nonpalpable and intramuscular Norplant capsules. Am J Obstet Gynecol 1998; 178:1185-1193. (35) Mansour D. UK provision for removal of non-palpable contraceptive implants. J Fam Plann Reprod Health Care 2009; 35:3-4. (36) For a woman using the etonogestrel implant, Implanon, which has been found to be located in her biceps muscle, should it be removed under local anaesthetic? Members' Enquiry 1766. 20-9-2006. Faculty of Sexual & Reproductive Healthcare. Ref Type: Report (37) James P, Trenery J. Ultrasound localisation and removal of non-palpable Implanon implants. Aust NZ J Obstet Gynaecol 2006; 46:225-228. (38) Vidin E, Garbin O, Rodriguez B, Favre R, Bettahar-Lebugle K. Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases. Contraception 2007; 76:35-39. (39) C v Sefton Primary Care Trust Lawtel LTLPI 24/8/2005. 2005. Ref Type: Report (40) Mansour D, Walling M, Glenn D, Egarter C, Graesslin O, Herbst J et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care 2008; 34:89-91. (41) Mourtialon P, Tixier H, Loffroy R, Maillart JC, Calmelet P, Dellinger P et al. Vascular complication after insertion of a subcutaneous contraceptive implant. Acta Obstetrica et Gynecologica Scandinavica 2008; 87:1256-1258. (42) Searle ES. Norplant neuropathy (letter). Br J Fam Planning 1994; 20:101. (43) Chang A, Edlich RF, Himel HN. Local reactions at the insertion site of the Norplant contraceptive system. Journal of Long-term effects of medical implants 1993; 3:305-312. (44) Sarma SP, Hatcher RA. Neurovascular injury during removal of levonorgestrel implants. Am J Obstet Gynecol 1995; 172:120-121. (45) Arribas-Mir L, Rueda-Lozano D, Agrela-Cardona M, Cedeño-Benavides T, Olvera-Porcel C, Bueno-Cavanillas A. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain. Contraception 2009. (46) Nash C, Staunton T. Focal brachial cutaneous neuropathy associated with Norplant® use: suggests careful consideration of the recommended site for inserting contraceptive implants. J Fam Plann Reprod Health Care 2001; 27:155-156. (47) Wechselberger G, Wolfram D, Pülzl P, Soelder E, Schoeller T. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol 2006; 195:323-326. (48) Webb AMC. Why go to Tiger Country? A report of two cases of Implanon® removal. J Fam Plann Reprod Health Care 2006; 32:193-194. (49) Marin R, McMillian D. Ulnar neuropathy associated with subdermal contraceptive implant. Southern Med J 1998; 91:875-878. (50) Smith JM, Conwit RA, Blumenthal PD. Ulnar nerve injury associated with removal of Norplant implants. Contraception 1998; 57:99-101. (51) Osman N, Mirlesse V. A new complication of contraceptive hormonal implant: about two cases of lesions of the ulnar nerve at the arm level [in French]. Gynécologie Obstétrique & Fertilité 2005; 33:322-325. (52) Bragg TWH, Jose RM, Bland JW, Matthews RN, Srivastava S. Implantable contraceptive devices: primum non nocere. J Fam Plann Reprod Health Care 2006; 32:190-192. (53) Nerve damage blamed on contraceptive implant placement. Clinician Reviews 2007; 17:15. (54) http://www.mhra.gov.uk/Onlineservices/Medicines/Druganalysisprints/index.htm (Accessed 22 July 2010). 2010. (55) Berner LS. Implants, Norplant: dejà vu all over again. J Women's Health 1995; 4:353-355.
URI:	http://wrap.warwick.ac.uk/id/eprint/4916